KinBio is wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific which had acquired the assets of Israel-based pharmaceutical company InSight.KinBio is developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars and biologics.

The company is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoporosis. .